Provider of integrated solutions for protein research in expression markers, at Philadelphia and Alconbury. England.
Specializes in interpretation of 2-dimensional gels, and developing point-of-care diagnostics in the areas of cystic fibrosis, cancer, infectious disease and aging. Includes alpha-amylase test, and research programs, with contacts in USA, Japan and headquarters in Sydney, Australia.
Developer of proteomics-based diagnostic products for the early detection of cancer by identifying proteins correlated with breast, bladder, prostate, cervical and colon cancers. Located in Newton, Massachusetts.
Small molecule drug development using proprietary technology to screen interactions with human proteins, in target-specific programs to present as clinical-stage compounds. Profile of company based in San Diego, California.
Business /
Biotechnology_and_Pharmaceuticals
|